H-Farm SpA

H-Farm SpA has a fully diluted share count of 200,156,925 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

Profitability and return metrics are not available for H-Farm SpA, as no valuation snapshot data has been computed. This absence prevents a direct comparison to industry_config preferred metrics or cohort medians for the Investment Management & Fund Operators industry.

The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the risk of overreliance on specific markets or product lines.

H-Farm SpA reported last actual revenue of 63,312,000 EUR, but no growth trajectory or outlook data is available for the current or next fiscal year. The absence of forward-looking guidance limits the ability to assess revenue momentum or strategic direction.

Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the lack of disclosed capital structure details and valuation metrics limits the ability to evaluate financial health comprehensively.

Recent events, including filings or transcripts, are not available in the provided data. This absence limits the ability to assess management commentary, strategic shifts, or regulatory developments that could impact the company's performance.

H-Farm generated EUR 31.96 million in free cash flow in fiscal year 2022, demonstrating strong cash generation capabilities.

The company reported a net income of EUR 34.38 million in fiscal year 2022, indicating significant profitability during that period.

Long-term debt decreased substantially to EUR 2.80 million in fiscal year 2022, reflecting a strengthened balance sheet position.

Operating income improved by 31.1% year-over-year in the latest reported period, showing progress in operational efficiency.

Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.

Revenue declined at a compound annual growth rate of 12.0% over the four-year period ending in the latest fiscal year.

The company reported a net loss of EUR 7.95 million in the most recent fiscal year, reversing previous profitability.

Free cash flow turned negative, reaching EUR -10.86 million in the latest fiscal year, indicating cash burn.

Operating income remained negative at EUR -7.62 million in the latest fiscal year, highlighting ongoing core operational losses.

Total assets contracted with a compound annual growth rate of -4.7% over five years, signaling balance sheet shrinkage.

Revenue €36.8M, +3,6% YoY; Operating income −9,3% YoY.

• ▍Revenue €36.8M, +3,6% YoY
• ▍Operating income −9,3% YoY
• ▍Net income +532,7% YoY
• ▍Free cash flow +394,2% YoY
• ▍Net margin 93.5%

Revenue €41.3M, −30,2% YoY; Operating income −2,4% YoY.

• ▍Revenue €41.3M, −30,2% YoY
• ▍Operating income −2,4% YoY
• ▍Net income +414,0% YoY
• ▍Net margin 43.0%

Revenue €59.1M; Operating income -€10.8M.

• ▍Revenue €59.1M
• ▍Operating income -€10.8M
• ▍Net margin -9.6%